MicroRNA‐204‐5p Deficiency within the vmPFC Region Contributes to Neuroinflammation and Behavioral Disorders via the JAK2/STAT3 Signaling Pathway in Rats
Source abstract
Abstract
Abstract Major depressive disorder (MDD) is usually considered associate with immune inflammation and synaptic injury within specific brain regions. However, the molecular mechanisms underlying the neural deterioration resulting in depression remain unclear. Here, it is found that miR‐204‐5p is markedly downregulated in the ventromedial prefrontal cortex (vmPFC) in a chronic unpredictable mild stress (CUMS) induce rat model of depression. Knockdown of miR‐204‐5p in the vmPFC of normal rats results in depression and anxiety‐like behaviors accompanied with the activation of microglia, elevated levels of pro‐inflammatory cytokines, and increased numbers of neural apoptotic cells, effects which appear to be mediated by activation of the JAK2/STAT3 signaling pathway. Electrophysiological recordings further demonstrate that knockdown of miR‐204‐5p induces abnormal excitability of pyramidal neurons. In contrast, upregulation of miR‐204‐5p in the vmPFC of CUMS rats significantly causes inhibition of JAK2/STAT3 signaling pathway, improvements in neuronal impairments, and an abolition of the depression and anxiety‐like behaviors. Moreover, pharmacological blocking of the JAK2/STAT3 signaling pathway significantly ameliorates abnormal behaviors resulting from miR‐204‐5p deficiency within the vmPFC. Collectively, these results provide robust evidence that the miR‐204‐5p/JAK2/STAT3 pathway may critically involve in the pathogenesis of depression, which may serve as potentially critical therapeutic target in the treatment of MDD.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Tryptophan and brain disorders · Neuroinflammation and Neurodegeneration Mechanisms · Stress Responses and Cortisol
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Key Laboratory of Mental Disorders The Second Hospital of Shandong University School of Basic Medical Sciences Shandong University Jinan Shandong 250012 China
Department of Endocrinology and Metabolism The Second Hospital of Shandong University Jinan Shandong 250033 China
Department of Medical Psychology and Ethics School of Basic Medical sciences Cheeloo College of Medicine Shandong University Jinan Shandong 250012 China
Funding
National Natural Science Foundation of China
References (60)
Show source-provided references
1. 10.1038/s41386-021-01101-710.1038/s41386-021-01101-7 ↗
2. 10.1016/j.biopsych.2005.05.00110.1016/j.biopsych.2005.05.001 ↗
3. 10.1097/00004583-199809000-0001010.1097/00004583-199809000-00010 ↗
4. 10.1038/cdd.2012.9610.1038/cdd.2012.96 ↗
5. 10.2147/OTT.S21599810.2147/OTT.S215998 ↗
6. 10.3390/jcm801008810.3390/jcm8010088 ↗
7. 10.17219/acem/12191810.17219/acem/121918 ↗
8. 10.1074/jbc.RA119.01204710.1074/jbc.RA119.012047 ↗
9. 10.1186/s12974-020-01787-410.1186/s12974-020-01787-4 ↗
10. 10.1186/s12951-022-01332-w10.1186/s12951-022-01332-w ↗
11. 10.1016/j.pnpbp.2017.07.02410.1016/j.pnpbp.2017.07.024 ↗
12. 10.1038/nm.358210.1038/nm.3582 ↗
13. 10.1038/npp.2017.910.1038/npp.2017.9 ↗
14. 10.2147/NDT.S25115210.2147/NDT.S251152 ↗
15. 10.1002/jcb.2618110.1002/jcb.26181 ↗
16. 10.3171/2017.5.JNS16316510.3171/2017.5.JNS163165 ↗
17. 10.1007/s11064-019-02931-010.1007/s11064-019-02931-0 ↗
18. 10.1152/ajpcell.00001.202010.1152/ajpcell.00001.2020 ↗
19. Zhao J. · Int. J. Mol. Med. · 2019 · 43 · 1167
20. Wang B. Q. · J. Physiol. Pharmacol. · 2023 · 74 · 347
21. 10.1177/0960327121100997010.1177/09603271211009970 ↗
22. 10.1016/j.yexcr.2019.04.02310.1016/j.yexcr.2019.04.023 ↗
23. Jiang W. · Int. J. Mol. Med. · 2020 · 45 · 1851
24. 10.1038/s41420-022-00885-x10.1038/s41420-022-00885-x ↗
25. 10.1021/acschemneuro.3c0004710.1021/acschemneuro.3c00047 ↗
26. 10.1186/s12974-021-02299-510.1186/s12974-021-02299-5 ↗
27. 10.1002/jcp.2933410.1002/jcp.29334 ↗
28. 10.1016/j.expneurol.2021.11369010.1016/j.expneurol.2021.113690 ↗
29. 10.1146/annurev-med-051113-02453710.1146/annurev-med-051113-024537 ↗
30. 10.1038/s41598-019-42633-910.1038/s41598-019-42633-9 ↗
31. Wu Y. · Mol. Med. Rep. · 2018 · 17 · 5007
32. 10.1080/15376516.2022.212870510.1080/15376516.2022.2128705 ↗
33. Liu H. · Histol. Histopathol. · 2020 · 35 · 1353
34. 10.1186/1742-2094-7-5410.1186/1742-2094-7-54 ↗
35. 10.1016/j.neures.2018.05.00210.1016/j.neures.2018.05.002 ↗
36. 10.1158/0008-5472.CAN-07-124310.1158/0008-5472.CAN-07-1243 ↗
37. 10.1016/S0140-6736(16)30383-X10.1016/S0140-6736(16)30383-X ↗
38. 10.1111/j.0065-1591.2000.acp29-03.x10.1111/j.0065-1591.2000.acp29-03.x ↗
39. 10.1017/S003329170400412X10.1017/S003329170400412X ↗
40. 10.1016/j.ynstr.2021.10038110.1016/j.ynstr.2021.100381 ↗
41. 10.1196/annals.1401.02910.1196/annals.1401.029 ↗
42. 10.1016/j.neuron.2005.02.01410.1016/j.neuron.2005.02.014 ↗
43. 10.1001/archpsyc.61.2.16810.1001/archpsyc.61.2.168 ↗
44. 10.1038/sj.onc.120392510.1038/sj.onc.1203925 ↗
45. 10.1097/ANA.000000000000033110.1097/ANA.0000000000000331 ↗
46. 10.1016/j.expneurol.2020.11335910.1016/j.expneurol.2020.113359 ↗
47. 10.1037/a003530210.1037/a0035302 ↗
48. 10.1002/da.2208410.1002/da.22084 ↗
49. 10.1097/PSY.0b013e31820ad12b10.1097/PSY.0b013e31820ad12b ↗
50. 10.1016/j.bbi.2006.08.00910.1016/j.bbi.2006.08.009 ↗
51. 10.3389/fgene.2012.0012010.3389/fgene.2012.00120 ↗
52. 10.1056/NEJMoa120902610.1056/NEJMoa1209026 ↗
53. 10.1038/sj.onc.121003110.1038/sj.onc.1210031 ↗
54. 10.1158/0008-5472.CAN-07-059310.1158/0008-5472.CAN-07-0593 ↗
55. 10.1016/j.nbd.2013.09.00310.1016/j.nbd.2013.09.003 ↗
56. 10.1007/s11064-022-03655-410.1007/s11064-022-03655-4 ↗
57. 10.1016/j.brainres.2014.07.01510.1016/j.brainres.2014.07.015 ↗
58. 10.18632/oncotarget.697410.18632/oncotarget.6974 ↗
59. 10.1038/aps.2016.15510.1038/aps.2016.155 ↗
60. 10.1016/j.ymthe.2021.11.00610.1016/j.ymthe.2021.11.006 ↗